Sirtris Pharmaceuticals, Inc. 4
4 · Sirtris Pharmaceuticals, Inc. · Filed Jan 24, 2008
Insider Transaction Report
Form 4
Jirousek Michael
Senior VP, Research
Transactions
- Sale
Common Stock
2008-01-22$13.07/sh−182$2,379→ 32,500 total - Sale
Common Stock
2008-01-22$13.01/sh−200$2,602→ 32,682 total
Footnotes (1)
- [F1]Sale was effected pursuant to a Rule 10b5-1 Trading Plan previously entered into by Reporting Person.